International Vaccine Institute

This study tests a new vaccine (IP-QSV) designed to protect against four types of Shigella bacteria, which cause severe diarrhea. The trial will include 370 healthy adults, children, and infants in Mali. Researchers will check if the vaccine is safe and triggers a strong immune r…

This early-stage study tests a new oral cholera vaccine called DuoChol in 60 healthy adults aged 18 to 45 in Sweden. Participants will receive two doses of either DuoChol or an existing vaccine (Dukoral) to compare safety and immune response. The goal is to gather initial data to…

This large study will test the LC16m8 mpox vaccine in nearly 12,000 people aged one year and older in the Democratic Republic of Congo. Researchers want to see if the vaccine can prevent mpox disease and monitor its safety. Participants will receive the vaccine as part of the gov…